Yantai Luyin Pharmaceutical

Yantai Luyin Pharmaceutical is a Chinese pharmaceutical company headquartered in Yantai, Shandong Province, that focuses on the development and manufacturing of chemical drugs. The company specializes in therapeutic areas including cardiovascular and cerebrovascular diseases, endocrinology, and anti-infectives. Its commercial portfolio features several essential generic medicines, such as Aspirin Enteric-coated Tablets and Nifedipine Sustained-release Tablets, which are produced in its GMP-certified facilities. Formerly a subsidiary of the publicly listed Luyin Investment Group, the company was acquired by Shandong Pharmaceutical Holding in 2019 as part of a strategic reorganization. Yantai Luyin continues to operate as a key manufacturer in the Chinese domestic market, providing high-quality generic formulations.